ADx NeuroSciences Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
21
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$40.6M
ADx NeuroSciences General Information
Description
Developer of biomarker assays intended to detect neurodegenerative diseases. The company offers reliable assays for cerebrospinal fluid (CSF) and blood developed to detect diseases such as Alzheimer's disease, Parkinson's disease and traumatic brain injury, enabling healthcare providers save the life of patients.
Contact Information
Website
www.adxneurosciences.com(Operating Subsidiary)
Corporate Office
- Technologiepark 6
- 9052 Ghent
- Belgium
Corporate Office
- Technologiepark 6
- 9052 Ghent
- Belgium
ADx NeuroSciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 08-Aug-2022 | $40.6M | Completed | Generating Revenue | ||
| 6. Grant | 04-Dec-2019 | Completed | Generating Revenue | |||
| 5. Angel (individual) | 25-Apr-2018 | Completed | Generating Revenue | |||
| 4. Grant | 26-Jan-2017 | Completed | Generating Revenue | |||
| 3. Angel (individual) | 30-Mar-2016 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 02-Jul-2015 | $396K | $396K | Completed | Startup | |
| 1. Angel (individual) | Completed | Startup |
ADx NeuroSciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class D | ||||||||
| Class D | ||||||||
| Class C | ||||||||
| Class B | ||||||||
| AA Class | ||||||||
| Class C | 625 | $246.25 | $246.25 | 1x | $246.25 | 2.04% | ||
| Class B | 1,150 | $246.25 | $246.25 | 1x | $246.25 | 3.76% |
ADx NeuroSciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ADx NeuroSciences Patents
ADx NeuroSciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3242134-A1 | Assay for the diagnosis of a neurological disease | Inactive | 04-May-2016 | ||
| US-20190113527-A1 | Assay for the diagnosis of a neurological disease | Inactive | 04-May-2016 | ||
| EP-3452830-B1 | Assay for the diagnosis of a neurological disease | Active | 04-May-2016 | ||
| EP-3452830-A1 | Assay for the diagnosis of a neurological disease | Active | 04-May-2016 | ||
| GB-201312226-D0 | Improved antibodies | Inactive | 08-Jul-2013 | C07K16/18 |
ADx NeuroSciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ADx NeuroSciences Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alzheimers Drug Discovery Foundation | Not-For-Profit Venture Capital | |||
| Vlaanderen verbeelding werkt | Limited Partner |
ADx NeuroSciences FAQs
-
When was ADx NeuroSciences founded?
ADx NeuroSciences was founded in 2011.
-
Where is ADx NeuroSciences headquartered?
ADx NeuroSciences is headquartered in Ghent, Belgium.
-
What is the size of ADx NeuroSciences?
ADx NeuroSciences has 21 total employees.
-
What industry is ADx NeuroSciences in?
ADx NeuroSciences’s primary industry is Diagnostic Equipment.
-
Is ADx NeuroSciences a private or public company?
ADx NeuroSciences is a Private company.
-
What is the current valuation of ADx NeuroSciences?
The current valuation of ADx NeuroSciences is .
-
What is ADx NeuroSciences’s current revenue?
The current revenue for ADx NeuroSciences is .
-
How much funding has ADx NeuroSciences raised over time?
ADx NeuroSciences has raised $1.4M.
-
Who are ADx NeuroSciences’s investors?
Alzheimers Drug Discovery Foundation and Vlaanderen verbeelding werkt have invested in ADx NeuroSciences.
-
When was ADx NeuroSciences acquired?
ADx NeuroSciences was acquired on 08-Aug-2022.
-
Who acquired ADx NeuroSciences?
ADx NeuroSciences was acquired by Fujirebio Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
